menu search

Thermo fisher cuts annual profit forecast on weak biotech demand

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt by lower-than-expec...

October 25, 2023, 6:08 am

Rsv vaccine shows hopeful early results in 50 to 59-year-olds, gsk says

GSK said they plan to submit data to regulators as soon as possible and expect a decision in 2024 on whether the shot, already approved for older adul...

October 25, 2023, 5:38 am

Gsk says latest arexvy respiratory vaccine trial results ‘positive'

GSK PLC (LSE:GSK, NYSE:GSK) today unveiled ‘positive' preliminary results from the third phase of its trial of Arexvy, a v...

October 25, 2023, 4:32 am

Gsk's rsv vaccine shows positive results in adults aged 50-59

British drugmaker GSK said on Wednesday its vaccine for respiratory syncytial virus (RSV) showed potent...

October 25, 2023, 2:25 am

Dynavax (dvax) to report q3 earnings: will it beat estimates?

On Dynavax's (DVAX) third-quarter earnings call, investors' focus is likely to be on the sales performance of the company's hepatitis B v...

October 24, 2023, 9:01 am

Astrazeneca said u.s. fda has accepted for review its flumist self-administered flu vaccine

AstraZeneca PLC AZN, -1.22% AZN, +1.45% said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of a self-adminis...

October 24, 2023, 7:21 am

Us fda accepts astrazeneca's self-administered flu vaccine for review

AstraZeneca said on Tuesday the U.S. Food and Drug Administration (FDA) has accepted for review the company's application seeking approval for patient...

October 24, 2023, 2:11 am

Moderna's stock suffering record losing streak as ‘investor caution remains high' over covid vaccine sales

Shares of Moderna Inc. were in danger of breaking their record for consecutive declines as investors express increasing caution over slowing sales of ...

October 23, 2023, 12:58 pm

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Pfizer gets fda green light for new shot that can streamline teenagers' vaccinations

Pfizer Inc. PFE, -1.80% said Friday that the U.S. Food and Drug Administration has approved the first five-in-one v...

October 20, 2023, 3:57 pm

Us fda approves pfizer's vaccine for meningococcal disease

The U.S. Food and Drug Administration (FDA) has approved Pfizer's vaccine Penbraya, making it the first...

October 20, 2023, 3:41 pm

Pfizer and moderna don't see eye to eye on this 1 particular point

Pfizer and Moderna recently launched updated coronavirus vaccines. The companies are monitoring current...

October 19, 2023, 5:00 am

Japan agreed to buy additional covid-19 vaccine doses from pfizer and moderna

Japan agreed to buy an additional 9 million COVID-19 vaccine doses from Pfizer and another 1 million do...

October 19, 2023, 3:40 am

Pfizer more than doubles price of covid vaccine

Pfizer is to more than double the US price of its Covid-19 antiviral medication Paxlovid as the use of the jab falls. In a statement, Pfizer said the...

October 19, 2023, 3:16 am

Pfizer to price covid drug paxlovid at $1,390 per course

Paxlovid will transition to the private market in November, which comes as demand for Covid vaccines an...

October 18, 2023, 5:57 pm

Hookipa pharma announces publication of preclinical data of hepatitis b virus (hbv) therapeutic vaccine developed in collaboration with gilead sciences

HB-400, a novel arenaviral therapeutic vaccine, generates robust T cell responses specific to hepatitis...

October 18, 2023, 11:01 am


Search within

Pages Search Results: